Rowinsky Eric K

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$118,935.66
Insider Sells Quantity
11
Insider Sells Sum
$14.7M

Insider Activity of Rowinsky Eric K

According to the SEC Form 4 filings, Rowinsky Eric K, being in a position of

  1. director at Biogen Inc.,
    оver the last 12 months, has bought 455 shares for $101,256, and sold 0 shares,
    over all time since 2012-01-06, has bought 455 shares for $101,256, and sold 63698 shares for $14.57M.

The largest purchase of all time was on 2024-02-15 and amounted to 455 shares of Biogen Inc. for $101,256.

The largest sale of all time was on 2015-03-20 and amounted to 23334 shares of Biogen Inc. for $6.24M.

Biography of Rowinsky Eric K

No biography is available at this moment.

2024-02-15PurchaseBiogen Inc.
BIIB
director
455
0.0003%
$222.54$101,256-4.2%
2023-02-10PurchaseFortress Biotech, Inc.
FBIO
director
11,976
0.0129%
$0.83$10,000-35.51%
2021-03-02SaleFortress Biotech, Inc.
FBIO
director
10,000
0.0113%
$4.45$44,500-33.33%
2021-02-19SaleFortress Biotech, Inc.
FBIO
director
8,000
0.0098%
$4.31$34,480-24.31%
2021-02-18SaleFortress Biotech, Inc.
FBIO
director
6,000
0.0074%
$4.20$25,200-21.62%
2021-02-16SaleFortress Biotech, Inc.
FBIO
director
2,000
0.0025%
$3.86$7,720-14.25%
2021-02-05SaleFortress Biotech, Inc.
FBIO
director
4,000
0.0048%
$3.80$15,200-13.81%
2017-09-05PurchaseVerastem, Inc.
VSTM
director
2,000
0.0053%
$3.84$7,680
2015-03-20SaleBiogen Inc.
BIIB
director
23,334
0.0056%
$267.41$6.24M-36.81%
2015-03-19SaleBiogen Inc.
BIIB
director
4,666
0.0011%
$247.98$1.16M-30.54%
2015-03-17SaleBiogen Inc.
BIIB
director
9,334
0.0023%
$242.64$2.26M-29.07%
2015-03-09SaleBiogen Inc.
BIIB
director
9,332
0.0023%
$238.53$2.23M-26.79%
2014-01-21SaleBiogen Inc.
BIIB
director
4,040
0.0017%
$310.09$1.25M+3.28%
2012-01-06SaleBiogen Inc.
BIIB
director
12,992
0.0052%
$110.27$1.43M+21.22%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.